hubei jumpcan pharmaceutical (600566.SH): In October, the company did not repurchase shares through centralized bidding trading method.

Gelonghui November 1st, hubei jumpcan pharmaceutical (600566.SH) announced that in October 2024, the company did not repurchase shares through centralized competitive trading. As of October 31, 2024, the company has repurchased a total of 180,500 shares through centralized competitive trading, accounting for 0.02% of the total share capital of the company. The highest purchase price was 29.00 yuan/share, the lowest price was 27.29 yuan/share, and the total amount paid was RMB 5,004,978 (excluding transaction costs).

Gelonghui FinanceNov 1 07:09 ET

Hubei Jumpcan Pharmaceutical's Q3 Profit Slides 7%; Shares Rise 4%

MT NewswiresOct 28 01:10 ET

Little Excitement Around Hubei Jumpcan Pharmaceutical Co., Ltd.'s (SHSE:600566) Earnings

Simply Wall StOct 26 21:37 ET

Hubei Jichuan Pharmaceutical Co., Ltd. Report for the Third Quarter of 2024

SZSIOct 25 12:00 ET · Announcements

Hubei Jumpcan Pharmaceutical Co., Ltd.'s (SHSE:600566) Last Week's 5.0% Decline Must Have Disappointed Private Companies Who Have a Significant Stake

Simply Wall StOct 11 03:37 ET

hubei jumpcan pharmaceutical (600566.SH): has repurchased a total of 0.1805 million shares.

Gelonghui September 30th | Hubei Jumpcan Pharmaceutical (600566.SH) announced that as of September 30, 2024, the company has repurchased a total of 180,500 shares through centralized bidding trading, accounting for 0.02% of the total share capital of the company. The highest purchase price is 29.00 yuan/share, the lowest price is 27.29 yuan/share, and the total amount paid is RMB 5,004,978 (excluding transaction costs).

Gelonghui FinanceSep 30 03:39 ET